Back to the future—Do IGT and IFG have value as clinical entities?
- 31 August 2008
- journal article
- editorial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 81 (2), 131-133
- https://doi.org/10.1016/j.diabres.2008.07.001
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: The Ely study 1990–2000Diabetic Medicine, 2007
- The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology GroupDiabetologia, 2006
- Follow-up Report on the Diagnosis of Diabetes MellitusDiabetes Care, 2003
- The Diabetes Risk ScoreDiabetes Care, 2003
- Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and interventionDiabetic Medicine, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.Diabetes Care, 2000
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979